CHINA HEALTH RESOURCE, INC. Financial Statements (2026 and earlier)

Company Profile

Business Address 343 SUI ZHOU ZHONG ROAD
SUI NING, SI CHUAN PROVINCE, 00000
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,0111,043 
Cash and cash equivalent1,0111,043 
Receivables6,0096,687 
Inventory, net of allowances, customer advances and progress billings1,7751,759✕
Inventory1,7751,759 
Prepaid expense5,580 ✕
Deferred costs6,4668,015 
Prepaid expense and other current assets✕✕3,539 
Other undisclosed current assets4,6414,208 
Total current assets:25,48325,252 
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization789796 
Other undisclosed noncurrent assets   
Total noncurrent assets:789796 
TOTAL ASSETS:26,27226,048 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:5,7735,759 
Taxes payable690670 
Accounts payable3,0093,041 
Accrued liabilities2,7642,717 
Other undisclosed accounts payable and accrued liabilities(690)(670) 
Debt11,00610,851 
Due to related parties419376 
Other undisclosed current liabilities(4,301)(4,334) 
Total current liabilities:12,89712,652 
Noncurrent Liabilities
Total liabilities:12,89712,652 
Equity
Equity, attributable to parent13,37513,395 
Common stock177177 
Additional paid in capital1,7361,736 
Accumulated other comprehensive income10,52110,741 
Retained earnings940740 
Total equity:13,37513,395 
TOTAL LIABILITIES AND EQUITY:26,27226,048 

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
Revenues
(Revenue, Net)		1,9341,230 
Cost of revenue(1,545)(968) 
Gross profit:390262 
Operating expenses(610)(326) 
Operating income (loss):(221)(64) 
Nonoperating income (expense)
(Other Nonoperating Income (Expense))		0(0) 
Interest and debt expense(107)(96) 
Income (loss) from continuing operations before equity method investments, income taxes:(328)(160) 
Other undisclosed income from continuing operations before income taxes10796 
Income (loss) from continuing operations:(221)(64) 
Income (loss) before gain (loss) on sale of properties:(221)(64) 
Net income (loss) available to common stockholders, diluted:(221)(64) 

Comprehensive Income ($ in thousands)
Annual | Quarterly

9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
Net income (loss):(221)(64) 
Comprehensive income (loss):(221)(64) 
Other undisclosed comprehensive income, net of tax, attributable to parent20078 
Comprehensive income (loss), net of tax, attributable to parent:(21)14 

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: